Jeff D’Agostino, CEO & President
Jeffrey D’Agostino founded 206 Ortho, Inc. in 2011. He is veteran of over 19 years in medical devices/pharmaceuticals including working with Pfizer, Immedica, Integra, Micro Therapeutics, and ev3. For the decade prior to founding 206 Ortho, Jeff gained extensive experience with several successful high growth/early stage medical device companies in neurosurgery and interventional neuroradiology focusing on marketing and sales. He also holds several pending patents related to medical devices.
Jeff’s educational background includes a bachelor’s of science with a major in psychology and a minor in biology. He earned an MBA at Babson College F.W. Olin School of business.
Steve Keaney, VP R&D
Steve Keaney brings his deep expertise in product development, including design and development of high strength materials to 206 Ortho’s team. He comes us having served previously at Viatar CTC Solutions Inc as the V.P. of Research and Development. Over the last 30 years, he has successfully driven both large and early stage R&D teams through all stages of medical device development, effectively navigating the regulatory process to product launch. He has developed materials for Edwards Lifesciences to create their Vantex antimicrobial catheters. He also led the disposables development of the Genesys HTA system at Boston Scientific. He has built quality systems at 3 startup companies obtaining ISO 13485 certification. His knowledge of minimally invasive surgical techniques and composites fabrication will help create a superior orthopedic device improving the quality of patient’s lives. Steve holds a B.S. in Plastics Engineering from the University of Massachusetts – Lowell and holds 8 patents in medical device design.
Rick Randall, Advisor
Rick Randall has dedicated the last 30 years of his career developing and commercializing game-changing medical devices into the global healthcare market. Most recently Rick was the President and CEO at OMNI Life Science. Prior to OMNI, Rick served as President & CEO for emerging-growth medical device companies, Medical Compression System, Avantis Medical, Trans1 Inc., Innovasive Devices Inc, and Target Therapeutics Inc. Has has managed commercial enterprises serving a wide range of medical markets including: interventional neurosurgery, orthopedic surgery, orthopedic arthroscopic surgery, minimally invasive spine surgery and gastrointestinal diagnostics.
Rick has created shareholder value through managing companies through three initial public offerings of stock on the NASDAQ Exchange and two strategic acquisitions. Mr. Randall is also co-founder of Conceptus, Inc and Cardima, Inc and has served on the Board of Directors of companies such as Conceptus (Bayer), Salient Surgical (Medtronic), Endocardial Solutions (St. Jude Medical), MicroTherapeutics (Covidien) and Microvention (Terumo).
Art Watterson, Ph.D, Scientific Advisor
Arthur Watterson, Ph.D, is a University of Massachusetts Lowell chemistry professor of 40 years. He served as chair of the department and has held leadership positions in his field of research including a position as the Director of the Institute for Nano Science and Engineering Technology at UML. He has been awarded numerous patents, has published over 200 publications and accrued many honors for his teaching. He is a resident of Nashua, NH.
Werner Blank, Scientific Advisor
Werner is a world renowned expert in the field of polymer and coating chemistry. He brings >50 years of experience in designing and synthesizing commercial polymers and catalysts for high performance applications in automotive, aerospace among other industries. Werner has more than 50 patents issued patents, and is well known for developing commercial resins with reduced emissions, increased cure response, and improved mechanical properties. www.wernerblank.com
Charlie Hegedus, Ph.D, Scientific Advisor
Dr. Hegedus brings over 35 years of experience in developing formulations of performance polymers and close industry relationships. He has worked in the Performance Materials Division at Air Products and Chemicals since 1993. Prior to joining Air Products, Hegedus was employed at the Naval Air Development Center where he was Technical Leader of the Protective Coatings Group. Dr. Hegedus holds >25 US patents and has authored over 65 papers and publications. He also serves on a number of national committees.
Andy Carter, Ph.D, Scientific Advisor
Andy is an expert in orthobiologics, orthopaedics, and biomaterials with more than 30 US patents and patent applications. Currently CTO at TheraCell Inc., Formerly: CTO at Anika Therapeutics (Nasdaq: ANIK); VP and General Manager at Spine Wave; 20 years at Smith and Nephew including Head of Materials Research, Program Manager, Orthopaedics and Group Director R&D at Smith and Nephew Endoscopy.